Breast Implant-Associated Anaplastic Large Cell Lymphoma: What the Primary Care Physician Needs to Know

Mo Med. 2020 Jul-Aug;117(4):380-382.

Abstract

This manuscript aims to outline the pertinent epidemiology, presentation, diagnosis, and treatment of patients who present with breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) as it pertains to primary care, such that the primary care physician (PCP) is able to appropriately care for patients with breast implants and counsel on risks of BIA-ALCL.

Publication types

  • Review

MeSH terms

  • Breast Implants / adverse effects*
  • Breast Implants / statistics & numerical data
  • Correlation of Data
  • Humans
  • Lymphoma, Large-Cell, Anaplastic / epidemiology
  • Lymphoma, Large-Cell, Anaplastic / etiology*
  • Mass Screening / methods
  • Mass Screening / standards*
  • Mass Screening / statistics & numerical data
  • Missouri / epidemiology
  • Postoperative Complications / epidemiology
  • Postoperative Complications / etiology
  • Primary Health Care / methods